| [1] |
LU Wei, WANG Yanmin, LIU Bingchen, TAO Xin, WANG Shipeng, CAO Qiuye.
Berberine enhances the chemotherapy sensitivity of prostate cancer cell line 22RV1 to docetaxel
[J]. Basic & Clinical Medicine, 2026, 46(1): 39-45.
|
| [2] |
LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu.
Advances in the mechanism of action of the ring finger proteins family in breast cancer
[J]. Basic & Clinical Medicine, 2026, 46(1): 124-128.
|
| [3] |
AN Xin, JIA Lin, Mawusumu·MAMUT, HUANG Zhipeng, KahrimanI·SLAM, Rexiati·REHEMAN, Hairila·WULAMU, Kerbanjiang·ABULIKIM, Jesur·BATUR.
Effects of ANGPT1 on proliferation,invasion and angiogenesis of mouse prostate cancer cell line RM-1
[J]. Basic & Clinical Medicine, 2025, 45(9): 1165-1172.
|
| [4] |
MA Yue, HUANG Conggang, WANG Yuan, XU Wenqing, LUO Zhihua.
Ginkgo biloba extract inhibits the proliferation and migration of human glioma cell line U87
[J]. Basic & Clinical Medicine, 2025, 45(9): 1144-1150.
|
| [5] |
ZOU Qingbo, ZHANG Guochen, PAN Changjing.
Gypenoside inhibits the proliferation, migration and invasion of prostate cancer cell line PC-3
[J]. Basic & Clinical Medicine, 2025, 45(8): 1059-1065.
|
| [6] |
JIN Xiaoxia, LIU Yushan, HU Jiping, ZHU Xinghua.
Expression of COA6 in breast cancer and its correlation with tumor immune cell infiltration
[J]. Basic & Clinical Medicine, 2025, 45(6): 755-761.
|
| [7] |
WANG Meng, SHEN Xuejing, LIU Jia, SHANG Lulu, ZHANG Mo.
Probe-based label-free SERS for identification of breast cancer-induced serum metabolic profiles in patients
[J]. Basic & Clinical Medicine, 2025, 45(5): 651-657.
|
| [8] |
ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang.
TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
[J]. Basic & Clinical Medicine, 2025, 45(5): 575-582.
|
| [9] |
LI Yunfan, ZOU Jiaming, WANG Yucheng, JU Rui, GUO Lei.
CTO inhibits the in situ growth of glioblastoma in mice and regulates the metabolism and inflammatory phenotype of glioma-associated microglia
[J]. Basic & Clinical Medicine, 2025, 45(4): 478-485.
|
| [10] |
LUO Yubei, HUANG Jianjun, YANG Wenxiu, ZHANG Junhong, LI Jing, Robert Chunhua ZHAO, DOU Xiaowei.
Establishment and preliminary study of four patient-derived primary breast cancer cell lines
[J]. Basic & Clinical Medicine, 2025, 45(2): 183-188.
|
| [11] |
JIANG Hua, ZHANG He, JIANG Songsong.
Sterol regulatory element binding protein 1 promotes proliferation and invision of prostate cancer cells
[J]. Basic & Clinical Medicine, 2025, 45(2): 189-196.
|
| [12] |
ZHANG Yanchi, SHI Junqi, ZHANG Yijun, DUAN Jiawen, LIU Jinyu, ZHANG Liyan, LIANG Wanping.
Advances in synergistic therapies targeting metabolic mechanisms and the immune microenvironment in breast cancer
[J]. Basic & Clinical Medicine, 2025, 45(12): 1662-1667.
|
| [13] |
LI Wenhui, REN Honggang, GUO Jian, SONG Yang, FENG Fuqiang.
miR-141-3p down-regulating lysophosphatidic acid receptor3 inhibits proliferation, migration and epithelial-mesenchymal transition of brain glioma cells
[J]. Basic & Clinical Medicine, 2025, 45(12): 1580-1587.
|
| [14] |
SU Lingfeng, WANG Huxia, WANG Yanfeng, SONG Zhangjun.
Impact of chronic stress on the development of breast cancer
[J]. Basic & Clinical Medicine, 2024, 44(9): 1303-1307.
|
| [15] |
XIAO Yanhong, JIANG Mingdong, LIN Yeyuan, RAN Can, LIANG Bo.
Scutellarin inhibits proliferation and migration of human prostate cancer cell line PC-3
[J]. Basic & Clinical Medicine, 2024, 44(9): 1229-1235.
|